• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Carl Zeiss Meditec, Optovue settle dispute

Article

Carl Zeiss Meditec and Optovue announced that they have resolved their legal disputes pending in the Northern District of California and in Massachusetts Superior Court.

Key Points

Dublin and Fremont, CA-Carl Zeiss Meditec and Optovue announced that they have resolved their legal disputes pending in the Northern District of California and in Massachusetts Superior Court. The parties have agreed to licensing and other terms and assurance of protection of disputed intellectual property. Additional terms of the settlement agreement remain confidential.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.